Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Punt, C. J. A.
Right arrow Articles by Eggermont, A. M. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Punt, C. J. A.
Right arrow Articles by Eggermont, A. M. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 13:1320, 2002
© 2002 European Society for Medical Oncology

Letters to the Editor

Reply to "Adjuvant interferon for melanoma", by K. Wheatley & N. Ives

C. J. A. Punt and A. M. M. Eggermont

University Medical Center St. Radboud, Department of Medical Oncology, Nijmegen, The Netherlands (E-mail: c.punt@onco.azn.nl)

The first 10% of the full text of this article appears below.

We thank Drs Wheatley and Ives for their valuable comments. We entirely agree with their views on the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
M. Maltoni, A. Caraceni, C. Brunelli, B. Broeckaert, N. Christakis, S. Eychmueller, P. Glare, M. Nabal, A. Vigano, P. Larkin, et al.
Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations--A Study by the Steering Committee of the European Association for Palliative Care
J. Clin. Oncol., September 1, 2005; 23(25): 6240 - 6248.
[Abstract] [Full Text] [PDF]